Home/ Stocks/ BBOT

BridgeBio Oncology Therapeutics, Inc. Common Stock

BBOT XNAS

$7.66 -0.20 (-2.54%) ▼ 15-min delayed

Open

$7.86

High

$7.99

Low

$7.64

Volume

238.2K

Market Cap

$613.66M

About BridgeBio Oncology Therapeutics, Inc. Common Stock

BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 92 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$0	$-134,044,000	$-4.30
FY 2025	$0	$-134,044,000	$-4.30
Q3 2025	$0	$-44,757,000	$-1.03
Q4 2025	$0	$-38,797,000	$2.19

Related Market News

No specific coverage for BBOT yet. Check out our latest market news or earnings calendar.

Get BBOT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on BridgeBio Oncology Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.